CLERAD-PROBE: Dosimetric analysis of I-124 PET–guided remnant radioiodine ablation in differentiated thyroid carcinoma.

Authors

Marieke Heinrich
Kerstin Michalski (ORCID: https://orcid.org/0000-0001-8715-7788)
R. Werner
Johannes Biko
Heribert Hänscheid (ORCID: https://orcid.org/0000-0003-1366-911X)
Constantin Lapa (ORCID: https://orcid.org/0000-0001-7536-2207)
Wofgang P Fendler
K Herrmann
Nicolas Schlegel
Andreas Buck
Manuel Weber
Peter Schneider

Institutions

University Hospital Augsburg (DE)
LMU Klinikum (DE)
Essen University Hospital (DE)
Universitätsklinikum Würzburg (DE)
Deutsches Konsortium für Translationale Krebsforschung (DE)
University of Duisburg-Essen (DE)
Ludwig-Maximilians-Universität München (DE)

Publication Details

Journal: Journal of Clinical Oncology
Published: 2026-05-27
DOI: https://doi.org/10.1200/jco.2026.44.16_suppl.3068
Primary Topic: Thyroid Cancer Diagnosis and Treatment
Type: article
Field-Weighted Citation Impact: 0.00

Funders

Deutsche Krebshilfe

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

CLERAD-PROBE: Dosimetric analysis of I-124 PET–guided remnant radioiodine ablation in differentiated thyroid carcinoma.

Marieke Heinrich, Kerstin Michalski, R. Werner, Johannes Biko et al.

May 27, 2026

Journal of Clinical Oncology

Thyroid Cancer Diagnosis and Treatment

article

CLERAD-PROBE: Dosimetric analysis of I-124 PET–guided remnant radioiodine ablation in differentiated thyroid carcinoma.

Marieke Heinrich, Kerstin Michalski, R. Werner, Johannes Biko, Heribert Hänscheid, Constantin Lapa, Wofgang P Fendler, K Herrmann, Nicolas Schlegel, Andreas Buck, Manuel Weber, Peter Schneider

May 27, 2026article en

Abstract

No abstract available for this paper.

Journal of Clinical OncologyVol. 44(16_suppl)

University Hospital Augsburg (DE), LMU Klinikum (DE), Essen University Hospital (DE), Universitätsklinikum Würzburg (DE), Deutsches Konsortium für Translationale Krebsforschung (DE), University of Duisburg-Essen (DE), Ludwig-Maximilians-Universität München (DE)

Deutsche Krebshilfe

Good health and well-being

Openalex Percentile: Top 7%

Thyroid Cancer Diagnosis and Treatment

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.